Enhanced assay granted approval by New York State’s Clinical Lab Evaluation Program (CLEP) for patients with DLBCL clonoSEQ is the only DLBCL MRD ...

Survival depends on different factors. So no one can tell you exactly how long you will live. Doctors usually work out the outlook for a certain disease by looking at large groups of people. Primary ...

A new study from researchers at the Oregon Health and Science University (OHSU) proposes a test called PAC-MANN, which could ...

Adaptive Biotechnologies (ADPT) has launched an upgraded version of its clonoSEQ assay for measurable residual disease detection in diffuse ...

NORTH CHICAGO, IL, USA I March 15, 2025 I AbbVie (NYSE: ABBV) today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the ...

Survival depends on many factors, so no one can tell you exactly how long you’ll live. It depends on your individual condition, type of cancer, treatment and level of fitness. Survival for testicular ...

Data generated using this assay and presented at ASH 2024 by Bond and colleagues demonstrated that in patients for which MRD was assessed by clonoSEQ, MRD negativity post-cycle six was highly ...

The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the blood of someone who doesn’t have the disease. When used alongside the ...